| Literature DB >> 33712998 |
Adam Stevens1, Reena Perchard2, Terence Garner2, Peter Clayton2, Philip Murray3.
Abstract
We present current knowledge concerning the pharmacogenomics of growth hormone therapy in children with short stature. We consider the evidence now emerging for the polygenic nature of response to recombinant human growth hormone (r-hGH). These data are related predominantly to the use of transcriptomic data for prediction. The impact of the complex interactions of developmental phenotype over childhood on response to r-hGH are discussed. Finally, the issues that need to be addressed in order to develop a clinical test are described.Entities:
Keywords: Growth hormone; Interactome; Pharmacogenomics; Transcriptomics
Mesh:
Substances:
Year: 2021 PMID: 33712998 PMCID: PMC7979669 DOI: 10.1007/s11154-021-09637-1
Source DB: PubMed Journal: Rev Endocr Metab Disord ISSN: 1389-9155 Impact factor: 6.514